Literature DB >> 11023720

Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants.

C Lass-Flörl1, P Rath, D Niederwieser, G Kofler, R Würzner, A Krezy, M P Dierich.   

Abstract

During a three-year period nine patients with haematological diseases after myeloablative chemotherapy died from invasive fungal infections caused by Aspergillus terreus. The hospital inanimate environment was monitored and A. terreus was cultured from potted plants in the vicinity of the patients. The patients (N = 14) and the environmental isolates (N = 2) were fingerprinted by RAPD-PCR with four different primers. Based on RAPD patterns the patients' isolates were differentiated into five different types; the environmental isolates represented two types. The isolates of four patients were identical to those found in the environment. Five additional patients were infected by RAPD types not found in the environment. One patient was infected with two different types. The data indicate a hospital-acquired infection in many of the patients and underline the need for careful environmental monitoring of units in which high-risk patients are housed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023720     DOI: 10.1053/jhin.2000.0799

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  23 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.

Authors:  Cornelia Lass-Flörl; Alexandra Rief; Sandra Leitner; Cornelia Speth; Reinhard Würzner; Manfred P Dierich
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study.

Authors:  Savita Jadhav; Tushar Sahasrabudhe; Vipul Kalley; Nageswari Gandham
Journal:  J Clin Diagn Res       Date:  2013-05-11

Review 6.  [Differential diagnosis for detection of hyphae in tissue].

Authors:  K Tintelnot
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 7.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

8.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

9.  Epidemiology of Aspergillus terreus at a university hospital.

Authors:  John W Baddley; Peter G Pappas; Anita C Smith; Stephen A Moser
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  New insight into amphotericin B resistance in Aspergillus terreus.

Authors:  Gerhard Blum; Caroline Hörtnagl; Emina Jukic; Thomas Erbeznik; Thomas Pümpel; Hermann Dietrich; Markus Nagl; Cornelia Speth; Günter Rambach; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.